Norges Bank Evogene Ltd. Transaction History

Norges Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$1.37 - $1.7 $317 - $394	-232 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$1.4 - $2.47 $324 - $573	232 New	232 $0
Q2 2019 Aug 09, 2019	SELL	$1.4 - $2.47 $9,081 - $16,022	-6,487 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$1.98 - $3.01 $12,844 - $19,525	6,487 New	6,487 $13,000
Q4 2018 Feb 08, 2019	SELL	$1.98 - $3.01 $12,844 - $19,525	-6,487 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$2.6 - $3.14 $16,866 - $20,369	6,487 New	6,487 $20,000
Q3 2018 Nov 09, 2018	SELL	$2.6 - $3.14 $16,866 - $20,369	-6,487 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$2.84 - $3.29 $18,423 - $21,342	6,487 New	6,487 $19,000
Q2 2018 Jul 23, 2018	SELL	$2.84 - $3.29 $18,423 - $21,342	-6,487 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$3.15 - $4.16 $20,434 - $26,985	6,487 New	6,487 $21,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.